{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:46:07Z","timestamp":1793324767967,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001808","name":"Kommission f\u00fcr Technologie und Innovation","doi-asserted-by":"publisher","award":["19300.1 PFLS-LS"],"award-info":[{"award-number":["19300.1 PFLS-LS"]}],"id":[{"id":"10.13039\/501100001808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12896-018-0424-3","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T10:40:58Z","timestamp":1521110458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobin-binding therapeutics"],"prefix":"10.1186","volume":"18","author":[{"given":"Christian A.","family":"Schaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy W.","family":"Deuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyen","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"Yalamanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre D.","family":"Scotney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Pelzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Soupourmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Buehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6468-4013","authenticated-orcid":false,"given":"Dominik J.","family":"Schaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"issue":"14","key":"424_CR1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1089\/ars.2016.6793","volume":"26","author":"CBF Andersen","year":"2017","unstructured":"Andersen CBF, Stodkilde K, Saederup KL, Kuhlee A, Raunser S, Graversen JH, Moestrup SK. Haptoglobin. Antioxid Redox Signal. 2017;26(14):814\u201331.","journal-title":"Antioxid Redox Signal"},{"key":"424_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fphys.2014.00415","volume":"5","author":"DJ Schaer","year":"2014","unstructured":"Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front Physiol. 2014;5:415.","journal-title":"Front Physiol"},{"issue":"1","key":"424_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.tibtech.2012.10.003","volume":"31","author":"AI Alayash","year":"2013","unstructured":"Alayash AI, Andersen CB, Moestrup SK, Bulow L. Haptoglobin: the hemoglobin detoxifier in plasma. Trends Biotechnol. 2013;31(1):2\u20133.","journal-title":"Trends Biotechnol"},{"issue":"2","key":"424_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/ars.2009.2923","volume":"12","author":"DJ Schaer","year":"2010","unstructured":"Schaer DJ, Alayash AI. Clearance and control mechanisms of hemoglobin from cradle to grave. Antioxid Redox Signal. 2010;12(2):181\u20134.","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"424_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/rccm.201510-2058OC","volume":"193","author":"CA Schaer","year":"2016","unstructured":"Schaer CA, Deuel JW, Schildknecht D, Mahmoudi L, Garcia-Rubio I, Owczarek C, Schauer S, Kissner R, Banerjee U, Palmer AF, et al. Haptoglobin preserves vascular nitric oxide signaling during hemolysis. Am J Respir Crit Care Med. 2016;193(10):1111\u201322.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"424_CR6","first-page":"2271","volume":"119","author":"FS Boretti","year":"2009","unstructured":"Boretti FS, Buehler PW, D'Agnillo F, Kluge K, Glaus T, Butt OI, Jia Y, Goede J, Pereira CP, Maggiorini M, et al. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and Guinea pigs. J Clin Invest. 2009;119(8):2271\u201380.","journal-title":"J Clin Invest"},{"key":"424_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.freeradbiomed.2015.09.016","volume":"89","author":"JW Deuel","year":"2015","unstructured":"Deuel JW, Vallelian F, Schaer CA, Puglia M, Buehler PW, Schaer DJ. Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Free Radic Biol Med. 2015;89:931\u201343.","journal-title":"Free Radic Biol Med"},{"key":"424_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.freeradbiomed.2015.04.023","volume":"85","author":"F Vallelian","year":"2015","unstructured":"Vallelian F, Garcia-Rubio I, Puglia M, Kahraman A, Deuel JW, Engelsberger WR, Mason RP, Buehler PW, Schaer DJ. Spin trapping combined with quantitative mass spectrometry defines free radical redistribution within the oxidized hemoglobin:haptoglobin complex. Free Radic Biol Med. 2015;85:259\u201368.","journal-title":"Free Radic Biol Med"},{"key":"424_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.freeradbiomed.2014.01.030","volume":"69","author":"TL Mollan","year":"2014","unstructured":"Mollan TL, Jia Y, Banerjee S, Wu G, Kreulen RT, Tsai AL, Olson JS, Crumbliss AL, Alayash AI. Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin. Free Radic Biol Med. 2014;69:265\u201377.","journal-title":"Free Radic Biol Med"},{"issue":"17","key":"424_CR10","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1089\/ars.2012.4547.test","volume":"18","author":"CE Cooper","year":"2013","unstructured":"Cooper CE, Schaer DJ, Buehler PW, Wilson MT, Reeder BJ, Silkstone G, Svistunenko DA, Bulow L, Alayash AI. Haptoglobin binding stabilizes hemoglobin ferryl iron and the globin radical on tyrosine beta145. Antioxid Redox Signal. 2013;18(17):2264\u201373.","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"424_CR11","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","volume":"121","author":"DJ Schaer","year":"2013","unstructured":"Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 2013;121(8):1276\u201384.","journal-title":"Blood"},{"issue":"4","key":"424_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1172\/JCI62972","volume":"122","author":"MT Gladwin","year":"2012","unstructured":"Gladwin MT, Kanias T, Kim-Shapiro DB. Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J Clin Invest. 2012;122(4):1205\u20138.","journal-title":"J Clin Invest"},{"issue":"5","key":"424_CR13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","volume":"32","author":"U Muller-Eberhard","year":"1968","unstructured":"Muller-Eberhard U, Javid J, Liem HH, Hanstein A, Hanna M. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood. 1968;32(5):811\u20135.","journal-title":"Blood"},{"issue":"4","key":"424_CR14","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI59770","volume":"122","author":"JH Baek","year":"2012","unstructured":"Baek JH, D'Agnillo F, Vallelian F, Pereira CP, Williams MC, Jia Y, Schaer DJ, Buehler PW. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in Guinea pigs by haptoglobin therapy. J Clin Invest. 2012;122(4):1444\u201358.","journal-title":"J Clin Invest"},{"issue":"4","key":"424_CR15","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/toxins6041244","volume":"6","author":"JH Baek","year":"2014","unstructured":"Baek JH, Zhang X, Williams MC, Schaer DJ, Buehler PW, D'Agnillo F. Extracellular Hb enhances cardiac toxicity in endotoxemic Guinea pigs: protective role of haptoglobin. Toxins (Basel). 2014;6(4):1244\u201359.","journal-title":"Toxins (Basel)"},{"issue":"4","key":"424_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjh.14280","volume":"175","author":"PA Shi","year":"2016","unstructured":"Shi PA, Choi E, Chintagari NR, Nguyen J, Guo X, Yazdanbakhsh K, Mohandas N, Alayash AI, Manci EA, Belcher JD, et al. Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function. Br J Haematol. 2016;175(4):714\u201323.","journal-title":"Br J Haematol"},{"issue":"3","key":"424_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","volume":"123","author":"JD Belcher","year":"2014","unstructured":"Belcher JD, Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI, Smith A, Nath KA, Hebbel RP, Vercellotti GM. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 2014;123(3):377\u201390.","journal-title":"Blood"},{"key":"424_CR18","doi-asserted-by":"crossref","unstructured":"Baek JH, Yalamanoglu A, Gao Y, Guenster R, Spahn DR, Schaer DJ, Buehler PW. Iron accelerates hemoglobin oxidation increasing mortality in vascular diseased Guinea pigs following transfusion of stored blood. JCI Insight. 2017;2(9):e93577.","DOI":"10.1172\/jci.insight.93577"},{"issue":"2","key":"424_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1083\/jcb.123.2.285","volume":"123","author":"M Wassler","year":"1993","unstructured":"Wassler M, Fries E. Proteolytic cleavage of haptoglobin occurs in a subcompartment of the endoplasmic reticulum: evidence from membrane fusion in vitro. J Cell Biol. 1993;123(2):285\u201391.","journal-title":"J Cell Biol"},{"issue":"40","key":"424_CR20","doi-asserted-by":"publisher","first-page":"14390","DOI":"10.1073\/pnas.0405692101","volume":"101","author":"KB Wicher","year":"2004","unstructured":"Wicher KB, Fries E. Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein. Proc Natl Acad Sci U S A. 2004;101(40):14390\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7416","key":"424_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nature11369","volume":"489","author":"CB Andersen","year":"2012","unstructured":"Andersen CB, Torvund-Jensen M, Nielsen MJ, de Oliveira CL, Hersleth HP, Andersen NH, Pedersen JS, Andersen GR, Moestrup SK. Structure of the haptoglobin-haemoglobin complex. Nature. 2012;489(7416):456\u20139.","journal-title":"Nature"},{"issue":"4","key":"424_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ng.3510","volume":"48","author":"LM Boettger","year":"2016","unstructured":"Boettger LM, Salem RM, Handsaker RE, Peloso GM, Kathiresan S, Hirschhorn JN, McCarroll SA. Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels. Nat Genet. 2016;48(4):359\u201366.","journal-title":"Nat Genet"},{"issue":"14","key":"424_CR23","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1089\/ars.2012.5089","volume":"19","author":"M Lipiski","year":"2013","unstructured":"Lipiski M, Deuel JW, Baek JH, Engelsberger WR, Buehler PW, Schaer DJ. Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in Guinea pigs to attenuate hemoglobin toxicity. Antioxid Redox Signal. 2013;19(14):1619\u201333.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"424_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1751-553X.2007.00898.x","volume":"29","author":"K Carter","year":"2007","unstructured":"Carter K, Worwood M. Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol. 2007;29(2):92\u2013110.","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"424_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/ars.2009.2793","volume":"12","author":"AP Levy","year":"2010","unstructured":"Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal. 2010;12(2):293\u2013304.","journal-title":"Antioxid Redox Signal"},{"issue":"16","key":"424_CR26","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.jacc.2015.07.076","volume":"66","author":"LE Cahill","year":"2015","unstructured":"Cahill LE, Jensen MK, Chiuve SE, Shalom H, Pai JK, Flint AJ, Mukamal KJ, Rexrode KM, Levy AP, Rimm EB. The risk of coronary heart disease associated with glycosylated hemoglobin of 6.5% or greater is pronounced in the Haptoglobin 2-2 genotype. J Am Coll Cardiol. 2015;66(16):1791\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"424_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jacc.2012.09.063","volume":"61","author":"LE Cahill","year":"2013","unstructured":"Cahill LE, Levy AP, Chiuve SE, Jensen MK, Wang H, Shara NM, Blum S, Howard BV, Pai JK, Mukamal KJ, et al. Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. J Am Coll Cardiol. 2013;61(7):728\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"424_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/ng.3534","volume":"48","author":"EJ Hollox","year":"2016","unstructured":"Hollox EJ, Wain LV. Recurrent mutation at the classical haptoglobin structural polymorphism. Nat Genet. 2016;48(4):347\u20138.","journal-title":"Nat Genet"},{"issue":"8","key":"424_CR29","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1182\/blood-2006-05-022327","volume":"108","author":"MJ Nielsen","year":"2006","unstructured":"Nielsen MJ, Petersen SV, Jacobsen C, Oxvig C, Rees D, M\u00f8ller HJ, Moestrup SK. Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein. Blood. 2006;108(8):2846\u20139.","journal-title":"Blood"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-018-0424-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12896-018-0424-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-018-0424-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T19:35:32Z","timestamp":1570908932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-018-0424-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s12896-018-0424-3","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"14 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal studies were approved by the FDA Institutional Animal Care and Use Committee, with all experimental procedures performed in adherence to the NIH guidelines on the use of experimental animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"15"}}